685 results on '"Gisselsson, David"'
Search Results
2. Hallmark discoveries in the biology of Wilms tumour
3. Diagnostic yield and clinical impact of germline sequencing in children with CNS and extracranial solid tumors—a nationwide, prospective Swedish study
4. Current and emerging sequencing-based tools for precision cancer medicine
5. Systematic orientation of fresh rectal suction biopsies improves histopathological diagnostics in hirschsprung’s disease – a method description and preliminary report
6. A Gradual Transition Toward Anaplasia in Wilms Tumor Through Tolerance to Genetic Damage
7. Weaponized genomics: potential threats to international and human security
8. Wargaming cancer: a strategy for future precision oncology?
9. Trailblazing precision medicine in Europe: A joint view by Genomic Medicine Sweden and the Centers for Personalized Medicine, ZPM, in Germany
10. Delineating the intra-patient heterogeneity of molecular alterations in treatment-naïve colorectal cancer with peritoneal carcinomatosis
11. Implementing precision medicine in a regionally organized healthcare system in Sweden
12. Histopathological dimensions differ between aganglionic and ganglionic bowel wall in children with Hirschsprung’s disease
13. Ultra high frequency ultrasonography to distinguish ganglionic from aganglionic bowel wall in Hirschsprung disease: A first report
14. Modelling evolution at the boundaries of solid tumours: Cancer phylodynamics
15. Anti-tumor effects of rigosertib in high-risk neuroblastoma
16. Abstracts from the 3rd Conference on Aneuploidy and Cancer: Clinical and Experimental Aspects
17. Diagnostic Yield From a Nationwide Implementation of Precision Medicine for all Children With Cancer
18. Logistics for Rapid Isolation of Viruses From Humans.
19. Abstract PR003: Multi-drug adaptive therapy protocol in vitro: An exercise in optimization for neuroblastoma
20. DEVOLUTION—A method for phylogenetic reconstruction of aneuploid cancers based on multiregional genotyping data
21. Weaponized genomics: potential threats to international and human security
22. Gradual transition towards anaplasia in Wilms tumor through tolerance to genetic damage
23. Structural and Numerical Chromosome Changes in Colon Cancer Develop through Telomere-Mediated Anaphase Bridges, Not through Mitotic Multipolarity
24. Hallmark discoveries in the biology of Wilms tumour
25. Clonal competition within complex evolutionary hierarchies shapes AML over time
26. Chemotherapy, host response and molecular dynamics in periampullary cancer: the CHAMP study
27. Telomere Dysfunction Triggers Extensive DNA Fragmentation and Evolution of Complex Chromosome Abnormalities in Human Malignant Tumors
28. Chromosomal Breakage-Fusion-Bridge Events Cause Genetic Intratumor Heterogeneity
29. Four evolutionary trajectories underlie genetic intratumoral variation in childhood cancer
30. Table S3 from Resolving the Pathogenesis of Anaplastic Wilms Tumors through Spatial Mapping of Cancer Cell Evolution
31. Figure S1 from Resolving the Pathogenesis of Anaplastic Wilms Tumors through Spatial Mapping of Cancer Cell Evolution
32. Data from Resolving the Pathogenesis of Anaplastic Wilms Tumors through Spatial Mapping of Cancer Cell Evolution
33. SIX1 as a Novel Immunohistochemical Marker in the Differential Diagnosis of Rhabdomyosarcoma
34. Resolving the Pathogenesis of Anaplastic Wilms Tumors through Spatial Mapping of Cancer Cell Evolution
35. Neuroblastoma patient-derived orthotopic xenografts reflect the microenvironmental hallmarks of aggressive patient tumours
36. Building a precision medicine infrastructure at a national level: The Swedish experience
37. Data from Branching Copy-Number Evolution and Parallel Immune Profiles across the Regional Tumor Space of Resected Pancreatic Cancer
38. Supplementary Data from Branching Copy-Number Evolution and Parallel Immune Profiles across the Regional Tumor Space of Resected Pancreatic Cancer
39. Figure S2 from Patient-Derived Xenograft Models Reveal Intratumor Heterogeneity and Temporal Stability in Neuroblastoma
40. Supplementary table 6-7 from Patient-Derived Xenograft Models Reveal Intratumor Heterogeneity and Temporal Stability in Neuroblastoma
41. Data from Patient-Derived Xenograft Models Reveal Intratumor Heterogeneity and Temporal Stability in Neuroblastoma
42. Supplementary Methods from Patient-Derived Xenograft Models Reveal Intratumor Heterogeneity and Temporal Stability in Neuroblastoma
43. Supplementary Data from Extensive Clonal Branching Shapes the Evolutionary History of High-Risk Pediatric Cancers
44. Supplementary table 3-5 from Patient-Derived Xenograft Models Reveal Intratumor Heterogeneity and Temporal Stability in Neuroblastoma
45. Supplementary Figure S1 from Distinct Mitotic Segregation Errors Mediate Chromosomal Instability in Aggressive Urothelial Cancers
46. Supplementary table 8-14 from Patient-Derived Xenograft Models Reveal Intratumor Heterogeneity and Temporal Stability in Neuroblastoma
47. Data from Extensive Clonal Branching Shapes the Evolutionary History of High-Risk Pediatric Cancers
48. Supplementary Tables S1-S2 from Distinct Mitotic Segregation Errors Mediate Chromosomal Instability in Aggressive Urothelial Cancers
49. Supplementary table 1-2 from Patient-Derived Xenograft Models Reveal Intratumor Heterogeneity and Temporal Stability in Neuroblastoma
50. Macrophage infiltration promotes regrowth in MYCN-amplified neuroblastoma after chemotherapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.